INTRODUCTION
In a study of herpes simplex virus type 1 (HSV-1) sulphated glycoproteins, Hope et al. (1982) described a group of polypeptides of apparent molecular weights 32000, 34000 and 35000 (32K/34K/35K). These authors determined that over 95~ of the total amount of the 32K/34K/35K polypeptides synthesized was found in a free form in the medium, not associated with virus particles. This distribution suggested that these polypeptides might have an extraceltular function and stimulated us to investigate them further. Our studies were assisted by the production of a monoclonal antibody (MAb; 3114) that reacted with the 32K/34K/35K polypeptides.
The evidence presented by Hope et al. (1982) suggested that the polypeptides were related to glycoprotein D (gD), because a MAb (MA 140) precipitated both gD from intracellular virus and the 32K/34K/35K polypeptides from the supernatant of infected cells. The original MAb, 3114, did the same, but this was later shown to be a misleading coincidence. The present paper shows that the 32K/34K/35K polypeptides are related to glycoprotein E-1 (gE-1).
Glycoprotein E is an HSV glycoprotein with affinity for the Fc region of IgG (Baucke & Spear, 1979) and is present on the surface of both virions and infected cells (Para et al., 1980) . These properties led us to examine whether the 32K/34K/35K polypeptides retained the Fcbinding properties characteristic of gE.
We have also investigated the genesis of 32K/34K/35K and found that in the absence of serum the polypeptides did not appear in the medium and that they could be generated from gE-l by a serum component or components.
METHODS
Cells and virus. P3-X67-Ag8 myeloma cells originally produced by Dr Cesar Milstein were kindly supplied by Dr Rob Webster. They were grown in Dulbecco's modification of Eagle's MEM (Flow Laboratories) containing 7-5 horse serum and 7.5~ foetal calf serum supplemented with 4 mM-glutamine and antibiotics. Baby hamster kidney (BHK) cells (clone 13) (Macpherson & Stoker, 1962) were grown in Eagle's MEM (EMEM) supplemented with 10~ calf serum. The viruses used were HSV-1 strain 17 syn ÷ (Brown et al., 1973) , the derived temperaturesensitive mutant tsK (Marsden et al., 1976) and HSV-2 strain HG52 (Timbury, 1971 Hybridoma lines. BALB/c mice were immunized with BHK cells infected with tsK grown at the non-permissive temperature of 38.5 °C for 24 h. Mice received three intraperitoneal injections at fortnightly intervals each of 5 x l05 cell equivalents of antigen in complete Freund's adjuvant~ Three months after the third injection they were boosted intravenously with 2 x 106 cell equivalents. After 3 days they were killed, then their spleens were removed and fused with P3-X67-Ag8 myeloma cells at a 10:1 ratio (K6hler & Milstein, 1975) using polyethylene glycol (PEG) 1000. The fused cells were washed and plated out in microtitre plates (3 x l05 cells/well) in medium containing hypoxanthine, aminopterin and thymidine. The contents of each well were grown to the 50 ml flask stage and then frozen while the supernatant was tested by immunoprecipitation. Lines were cloned in soft agar over a feeder layer of mouse spleen cells. Discrete colonies were picked under a microscope and grown. Monoclonal antibodies against gB (2975), gD (2001/1) and gE (3104) were produced in the same way. These lines were cloned and by immunoprecipitation reacted only with the glycoproteins indicated.
Labelling procedures. HSV-1 strain 17 was grown in BHK cells in EMEM with either 5 ~ calf serum or 20~ calf serum and 10~ tryptose phosphate broth. The m.o.i, was 20 p.f.u, per cell and virus was allowed to adsorb for 1 h at 37 °C. After adsorption, the infected cells were further incubated for 5 h at 37 °C in EMEM with one-fifth the usual amount of methionine and 2 ~ calf serum. They were then washed with phosphate-buffered saline (PBS) and incubated for a further 2.5 h in PBS containing 20 ~tCi/ml [35S]methionine (Amersham). After scraping the infected cells into ice-cold PBS they were centrifuged at 2000 r.p.m, for 5 min, resuspended in PBS and stored at -70 °C. Before use, 1 ~ NP40 (BDH) was added to the infected cells, then they were sonicated and incubated for 1 h at 4 °C. After centrifugation at 10000 r.p.m, for 5 rain, the supernatant was used for immunoprecipitation.
Except for pulse-chase experiments, of which details are given in the Results section, labelling with 3~S-labelled inorganic sulphate followed the same schedule as for [35S] methionine, but the medium after virus adsorption was sulphate-free EMEM containing 2~ calf serum, and infected cells were labelled in PBS containing 500 ~tCi/ml inorganic 3sSO~ (Amersham).
For [3H]mannose labelling the medium after adsorption was EMEM with 2~ calf serum. Infected cells were labelled in PBS containing 30 ~tCi/ml D-[2-3H]mannose (Amersham).
Immunoprecipitation. Hybridoma supernatant (50 gl), 20 ~tl of labelled infected cell extract and I0 ~tl of rabbit anti-mouse immunoglobulin antibody were incubated overnight at 4 °C. Antigen antibody complexes were precipitated by the addition of 100 ~1 of a 10~ suspension of heat-killed formalin-fixed Staphylococcus aureus (NCTC 8530; Kessler, 1981) and further incubated for 1 h at 4 °C. After centrifugation of the mixture at 14000 r.p.m, for 10 rain, the pellet was resuspended and washed three times by centrifugation in buffer containing 0.15 MNaCI, 0.1 M-Tris-HC1 pH 7.4 and 0.25~ NP40. Bound antigen was released by treatment with 0.2 M-glycine pH 2.5 for 30 rain at 4 °C. The bacteria were removed by centrifugation at 1400 r.p.m, and supernatants analysed by SDS-PAGE.
Tryptic peptide mapping. Immunoaffinity-purified proteins were first separated on 10~ SDS-polyacrylamide gels, which were dried immediately after electrophoresis. Four radioactive spots were placed at the corners of the gel to facilitate alignment of gel and film after autoradiography. Slices of the gel containing the desired polypeptides were cut out and the polypeptides eluted by the method of Anderson et al. (1973) . Polypeptides were desalted by passage through Sephadex G-25 and the SDS removed by the method of Henderson et al. (1979) . The pellet from this procedure was resuspended in 100 ~tl of a 1 ~ solution of ammonium bicarbonate containing 10 ~tg of TPCK-treated trypsin. After 16 h at 37 °C a further 5 ~g of TPCK-treated trypsin was added and incubation continued for 4 h. The peptides were lyophilized, oxidized with performic acid (Hirs, 1967) then diluted 50-fold with water and lyophilized again. Peptides in pH 2.1 electrophoresis buffer (acetic acid:formic acid:water, 8:2:90) were applied to a spot 4 cm from each of two adjacent edges of 20 cmx 20 cm Eastman cellulose chromatogram sheets (Eastman Kodak, no. 13255). After electrophoresis for 45 min at 600 V the chromatogram was dried in a current of cold air and peptides-were separated in the second dimension by ascending chromatography in water : butan-l-ol : pyridine : acetic acid, 24 : 30 : 20 : 6. Dried chromatograms were sprayed with En3Hance (New England Nuclear) and exposed at -70 °C to Kodak XS1 film.
Fc-affinity columns. Fc-affinity chromatography was performed as described by Baucke & Spear (1979) . Affinity columns were prepared by first covalently linking bovine serum albumin (BSA) to cyanogen bromide-activated Sepharose 4B (Pharmacia) according to the manufacturer's instructions and then binding anti-BSA IgG from rabbit serum (purified as described below).
The column was used to detect Fc-binding activity in three different protein preparations: a cytoplasmic extract of infected cells, proteins found in the medium of infected cells (Hope et al., 1982) and immunoaffinity-purified gE (see below). To prepare the cytoplasmic extract, labelled infected cell monolayers were incubated in PBS with 0.5~ NP40 for 15 min on ice. Nuclei were removed from the extract by centrifugation at 13000g for 10 min and the supernatant used. Protein preparations were run into and incubated in the Fc-affinity column (or control columns lacking antibody) for 15 min at 37 °C. The columns were then washed extensively with PBS containing 0.5 ~ NP40. Bound proteins were eluted with 3 M-sodium thiocyanate, 0.01 M-Tris-HC1 pH 7-8, in PBS with 0.5 NP40.
Immunoadsorbent columns. Monoclonal antibody-containing ascites fluid was clarified by centrifugation at 50 000 g for 30 min. IgG was purified by ammonium sulphate precipitation followed by fractionation on Sephacryl S-200. Peak fractions of IgG were linked to cyanogen bromide-activated Sepharose 4B according to the manufacturer's instructions. Sample preparation, binding to and elution from the columns were as described for Fc-afl]nity binding columns.
Gel electrophoresis. Proteins were analysed on SDS-polyacrylamide gels (either 10~ or 5 to 12.5~ gradient) cross-linked with N,N'-methylene bisacrylamide. Gels were impregnated with either PPO-DMSO (Laskey & Mills, 1975) or En3Hance and then dried and exposed at -70 °C to Kodak XS1 film.
RESULTS

The 3114 hybridoma line
Hybridoma line 3114 was derived by fusing P3-X67-Ag8 myeloma cells to spleen cells from a BALB/c mouse immunized with a homogenate of BHK cells that had been infected with HSV-1 mutant tsK and incubated at the non-permissive temperature. Despite the fact that this mutant is very restricted at the non-permissive temperature (Marsden et al., 1976 ) the immunized mice produced antibodies to all the major HSV-1 glycoproteins. The most likely reason is that the immunogen contained glycoproteins from the tsK virions initially used to infect BHK cells.
This fusion gave very large numbers of colonies, at least two per microtitre well. The cells in each well were grown and frozen without cloning while the supernatants were tested for antibody. Thus each supernatant could have contained antibodies derived from more than one colony. The immunoprecipitation pattern of 3114 was complex (Fig. 1, lane I) . The supernatant precipitated bands of 27K, a group of bands of 32K, 34K and 35K and bands which comigrated with gD, pgD and mD as demonstrated by immunoprecipitation with an anti-gD MAb (Fig. 1 , lane 2). The band marked mD (Fig. 1 , lane 2) was the multimer of gD first described by Eisenberg et al. (1982) . This immunoprecipitation pattern would not have been unexpected if the suggestion of Hope et al. (1982) that the 32K/34K/35K polypeptides are related to gD was correct. However the supernatant also precipitated bands which comigrated with pgE and gE as demonstrated by immunoprecipitation with an anti-gE MAb (Fig. 1, lane 3) . The 27K band was often coprecipitated with the 32K/34K/35K polypeptides but has not been further investigated.
The 3114 cells came from a well containing more than one colony, so it was necessary to clone them for further experiments. Cloning in soft agar resulted in lines with different specificities showing that the original 3114 was a mixture. Of the 25 clones established, 19 precipitated 32K/34K/35K but not gD (one example, clone 3114/109, is shown in Fig. 1 , lane 5), one, clone 3114/108, precipitated gD but not 32K/34K/35K (Fig. 1 , lane 6), three were still mixtures and precipitated both gD and 32K/34K/35K and two produced little or no antibody. Clone 3114/109 which precipitated 32K/34K/35K but not gD was selected for further study.
Immunoprecipitation with other MAbs supported the idea that the 32K/34K/35K polypeptides are related to gE. Four gD MAbs did not precipitate these polypeptides (for example Fig. 1 , lane 2 and Fig. 2, lane 10) . Two gE MAbs did, though less strongly than 3114/109 (one is shown in Fig. 2, lane 1) . Both 3114/109 and anti-gE precipitated a band of tool. wt. about 55K. In some gels this was seen as a double band and it is referred to as 55K/57K.
The characteristics of the 32K/34K/35K polypeptides precipitated by 31t4/109 antibody were investigated to see whether they were the same as those of the polypeptides described by Hope et al. (1982) . Antibody 3114/109 did not react with HSV-2-infected or mock-infected cells (Fig. 2, lanes 4 and 9 respectively) . This observation suggests that the 32K/34K/35K polypeptides were not BHK proteins and that any equivalent polypeptides induced by HSV-2 lacked the epitope recognized by the 3114/109 antibody. The polypeptides could be immunoprecipitated from HSV-l-infected cells labelled with [3SS]methionine (Fig. 2, lane 7) , inorganic 3sSO 4 (Fig. 2, lane 2) and [3H]mannose (Fig. 2, lane 12) and so appear to be glycoproteins. In all these characteristics these 32K/34K/35K polypeptides behave as those described by Hope et al. (1982) and we conclude that they are the same. 
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Tryptic peptide analyses of gD, gE, 32K/34K/35K and 55K/57K polypeptides
The proteins were first purified by immunoaffinity chromatography using MAbs directed against glycoproteins D, E and 32K/34K/35K. Fig. 3 shows an autoradiograph of proteins purified by immunoaffinity chromatography (lanes 2, 3, 4 and 6) from extracts of HSV-1-infected cells labelled with [35S]methionine from 5 h to 12 h after infection (lane 1) and from the growth medium of such cells (lane 5). The anti-gB MAb was used as a control to identify proteins non-specifically trapped on the columns. These are indicated on the right-hand side of the figure and include several high mol. wt. proteins (arrowed), probably of host origin, the host protein actin and the viral 63K and 43K polypeptides. The three proteins, gD, pgD and m D (Eisenberg et al., 1982) were specifically bound to and eluted from the anti-gD column (lane 2). Using the anti-gE column, gE and pgE were purified (lane 3) while from the 3114/109 MAb column the 32K/34K/35K and 55K/57K proteins were purified (lane 6).
To obtain single proteins for tryptic fingerprinting the immunoaffinity-purified proteins were separated by S D S -P A G E using a 10~ gel and individual bands were excised. Tryptic peptide maps were prepared and Fig. 4 shows that gE and the 32K/34K/35K and 55K/57K polypeptides gave similar maps, which were distinct from that of gD. The relatedness of gE, 32K/34K/35K and 55K/57K was unambiguously established by examination of the mixtures of tryptic peptides. These showed that the spots seen in the maps of the 32K/34K/35K polypeptides comigrated with the spots seen in the gE map, but not with the spots seen in the gD map. These results supported the immunological data and it could be concluded that the 32K/34K/35K and the 55K/57K polypeptides were encoded by the gene which encodes gE. In a similar manner we confirmed the results of Eisenberg et al. (1982) that the band labelled mD (Fig. 3 , lane 2) was related to gD (data not shown). (Fig. 3) were separated on 10~ SDS-polyacrylamide gels and the relevant proteins excised. Tryptic peptides were prepared for each protein as described and applied to thin layers of cellulose. The point of application (origin) appears as a black dot at the bottom left of each panel and peptides were separated first by electrophoresis (vertical direction of the fluorograph) then by ascending chromatography (horizontal direction of the fluorograph). To facilitate comparison some tryptic peptides have been designated with a number or a letter.
Although the apparent mol. wt. ofgE is approximately twice that of each of the 32K, 34K and 35K polypeptides, the tryptic peptide maps of gE contained no spots additional to those seen in the tryptic peptide maps of 32K, 34K and 35K. This raised the possibility that at least two of the 32K, 34K and 35K polypeptides were encoded by different regions of the gene encoding gE. To test this hypothesis, 32K, 34K and 35K proteins were first purified by immunoaffinity chromatography using the MAb 3l 14/109 column. The 32K, 34K and 35K polypeptides were individually cut out of 10~ SDS gels and tryptic peptides of each were prepared. Fig. 5 shows autoradiographs of the tryptic peptides and of a mixture of the 34K and 35K peptides. The patterns produced by 34K and 35K looked similar. Although the mixture of the 34K and 35K tryptic peptides had not run into the cellulose sheet as far as the individual 34K and 35K spots the pattern showed that the tryptic peptides of both 34K and 35K co-migrated. Furthermore, the map of the mixture of 34K and 35K tryptic peptides looked similar to the map of the 32K tryptic peptides. We concluded that each of the three polypeptides 32K, 34K and 35K were encoded, at least in part, by a common region of the gE gene. However, the reason why there were as many tryptic peptides in the map of 32K/34K/35K as in the map of gE remains unresolved.
Kinetics of appearance of 32K/34K/35K
BHK cells infected with HSV-1 were labelled with inorganic 35SO4 from 5 h to 7 h post infection. The label was then removed and replaced with E M E M containing 2~o calf serum. Infected cells and their growth medium were harvested at various times during this chase. The results of such an experiment, in which extracts of equal numbers of cells were loaded onto all tracks, are shown in Fig. 6 . Glycoproteins D and E were clearly seen in the whole cells during the 5 h to 7 h pulse label (lane 1). There was a significant decrease in the amount of gE in the infected cells during the chase in contrast to the amount of gD which remained relatively constant (lanes 2 to 5). The 32K/34K/35K polypeptides could not be detected in the growth medium during the 5 h to 7 h labelling period (supernatant, lane 6), but appeared in progressively increasing amounts during the 1 h, 3 h, 5 h and 16 h chases (lanes 7 to 10 respectively). Similar results were obtained with polypeptides pulse-labelled at 3 h and 7 h after infection (data not shown). These results were compatible with the hypothesis that glycoprotein E was modified, possibly by cleavage, to produce 32K/34K/35K.
The 32K/34K/35K polypeptides lack Fc-binding activity Baucke & Spear (1979) showed that gE binds to the Fc region of IgG. We were interested to see whether the property was retained by the 32K/34K/35K polypeptides. Fc-affinity columns and control columns lacking antibody were prepared. HSV-l-infected cells were labelled with inorganic ssso4 and equal volumes of either an infected cell extract or the growth medium from the infected cells were applied to the Fc-affinity or control columns and eluted as described. i ~ i ~ii ~i;iill " Fig. 6 . Kinetics of appearance of sulphated polypeptides induced by HSV-I. Infected cells were labelled with inorganic 35SO4 from 5 to 7 h after infection. At the end of this period, the label was removed and cells were then harvested immediately (lanes 1 and 6) or chased for various times (lanes 2 and 7, 1 h; lanes 3 and 8, 3 h; lanes 4 and 9, 5 h; lanes 5 and 10, 16 h) in medium containing no radioisotope. Polypeptide profiles from infected cell extracts (lanes 1 to 5) and from the supernatant growth medium (lanes 6 to 10) were obtained for each time point.
Those proteins which did not bind to the columns were also collected. The results are presented in Fig. 7 in which lanes 6' to 10' are longer exposures of lanes 6 to 10. In agreement with previous results (Hope et at., 1982) the major sulphated glycoprotein in cells infected with HSV-1 was more strongly bound by the Fc-affinity column (lane 2) than by the control column (lane 3). The 32K/34K/35K polypeptides were identified in the infected cell extract (lane 1) and in the growth medium (supernatant, lanes 6 and 6'). They did not bind to the Fc-affinity columns (lanes 2, 7 and 7') or to the control columns (lanes 3, 8 and 8'). It can be concluded that 32K/34K/35K do not bind to the Fc domain of IgG.
A surprising finding was that polypeptides which co-migrated with 32K/34K/35K appeared in greatly increased quantities in the flowthrough material of the infected cell extract from the Fc-affinity column (Fig. 7, lane 5) , compared with the flowthrough material from the control column (lane 4). This result suggested that 32K/34K/35K could be generated in an Fc-affinity column from gE. When the growth medium was applied to the Fc-affinity column and the control column the amounts of 32K/34K/35K in the non-binding fraction from each column Lanes 1 to 5, infected cells; lanes 6 to 10 and 6' to 10', supernatant. Extracts of infected cells labelled with inorganic 3sSO4 from 5 to 12 h after infection (lane 1) and the supernatant of a 2 h, 35000 g centrifugation of the growth medium from infected cells (lanes 6 and 6') were applied to Fc-affinity columns which contained antibodies directed against BSA absorbed to BSA Sepharose (lanes 2, 5, 7, 7', 10 and 10') and control columns (C) which contained only BSA Sepharose (lanes 3, 4, 8, 8', 9 and 9'). That part of the sample which came through the column without binding (lanes 4, 5, 9, 10, 9' and 10') was collected. After extensive washing, proteins bound to either the Fc-affinity column (lanes 2 and 7) or control column (lanes 3 and 8) were eluted with 3 M-sodium thiocyanate as described by Baucke & Spear (1979) . Lanes 6' to 10' are from an autoradiograph which was exposed for approximately seven times longer than that from which lanes 1 to 10 were taken.
were similar (compare lanes 10 and 9). This observation was consistent with there being i n t h e growth medium no gE from which 32K/34K/35K could be generated. Identical results to those shown in Fig. 7 were obtained with Fc-binding columns made with fl-gatactosidase linked to Sepharose 4B and anti-fi-galactosidase (data not shown).
Generation of 32K/34K/35K and 55K/57K by a serum component
Taken together the immunological, pulse~chase, fingerprinting and Fc-binding experiments suggested that the 32K/34K/35K polypeptides could be generated from gE-1 by a serum component. To test this hypothesis immunoaffinity-purified gE-1 (Fig. 8, lane 2) was incubated for 5 h at 37 °C either in the absence of serum (lane 3) or in the presence of 2 ~ calf serum (lane 4), 2~o human serum (lane 5) or 2~0 rabbit serum (lane 6). The experiment showed that gE was stable at 37 °C in the absence of serum (compare lanes 2 and 3) and that in the presence of calf or rabbit serum, but not human serum, polypeptides which co-migrated with 32K/34K/35K (lane I) accumulated. The amount of 32K/34K/35K detected after the addition of human serum to purified gE varied from experiment to experiment, but was consistently less than that produced by calf or rabbit serum. When serum was replaced by purified immunoglobulin the polypeptides were not generated (data not shown). BHK cells infected with HSV-I were pulse-labelled with 35804 from 5 to 6 h after infection, in the absence (lanes 1, 2, 5 and 6) or presence (lanes 3, 4, 7 and 8) of serum. Lanes 3 and 4, 2~. calf serum; lanes 7 and 8, 2~ human serum. The label was then removed and cells were either harvested immediately and extracted (lanes 1, 3, 5 and 7) or incubated for a further 5 h and then extracted (lanes 2, 4, 6 and 8) in PBS containing no serum. Lanes 3 to 8 show proteins appearing in the growth medium (these proteins were separated on a different gel).
5K 4K 2K
We investigated whether the 32K/34K/35K and 55K/57K appeared in the growth medium of infected cells only when the medium contained serum. Serum-starved BHK cells were infected with HSV-1 and pulse-labelled with inorganic 3sSO4 from 5 h to 6 h after infection in the absence or presence of calf or human serum. Infected cells labelled in the absence of serum were either harvested immediately (Fig. 9, lane 1) or incubated for a further 5 h in PBS containing no serum (lane 2). Figure 9 shows that despite the absence of serum, gE was synthesized. The growth medium of infected cells labelled in the presence of serum was either harvested immediately (lanes 3 and 7) or incubated for a further 5 h in PBS containing 2 ~ serum. In the absence of serum, the growth medium contained no detectable 32K/34K/35K either during the pulse (lane 5) or the subsequent chase (lane 6). In the presence of calf serum the growth medium contained minor amounts of 32K/34K/35K after the pulse (lane 3). After the chase the amounts of 32K/34K/35K increased considerably and some 55K/57K appeared (lane 4). In the presence of human serum no 32K/34K/35K was detected during the pulse although small amounts of 55K/57K appeared (lane 7). During the chase large amounts of 55K/57K but only small amounts of 32K/34K/35K appeared in the growth medium (lane 8). Other proteins released in the presence of serum were of unknown origin.
It could be concluded from this series of experiments that in HSV-l-infected cells in tissue culture gE-1 could be post-translationally modified to yield the 32K/34K/35K and 55K/57K polypeptides by a mechanism which involved at least one serum component. The component(s) could not be only immunoglobulin and the relative yield of particular polypeptides depended on the animal species from which the serum was obtained.
DISCUSSION
We have used tryptic peptide mapping and serological means to establish clearly that the 32K/34K/35K and 55K/57K polypeptides are related to gE. Previously Hope et al. (1982) found that a MAb, MA140, precipitated gD from virus-infected cells and the 32K/34K/35K polypeptides from infected cell supernatants. They concluded that these polypeptides were probably related to gD. This conclusion is now seen to have been erroneous. The antibodycontaining supernatant for these experiments was taken at an early stage in the development of the MA140 hybridoma line (J. Palfreyman, personal communication). This line now produces antibody that precipitates only gD. However we believe that originally the line, like 3114, was a mixture of clones and that the clone producing antibody to the 32K/34K/35K polypeptides later died out. It is commonly found that when two hybridoma lines are cultured together one outgrows the other. This explanation of the findings of Hope et al. (1982) appears the most likely one, but unfortunately cannot now be tested since no ceils were frozen from the MA140 line in its early stages.
When it first became apparent that the 32K/34K/35K polypeptides were related to gE we assumed that they were a part of the gE molecule, or that they were different from one another and together made up the gE molecule. Our data indicated that there were no substantial differences between the tryptic peptides of the individual 32K, 34K and 35K polypeptides, or between them and the 55K/57K tryptic peptides. Since gE appeared from its slower migration on SDS polyacrylamide gels to be much larger than 32K, and the predicted amino acid sequence of gE (McG eoch et al., 1985) shows no signs of a repeated oligomeric structure, these results are difficult to reconcile. Among the possible explanations which we have considered are the following. First, gE was unstable during preparation for trypsin digestion and broke down into the 32K/34K/35K portion of the molecule and a number of small fragments which were lost. Second, some of the tryptic peptides of gE were unstable. Third, some gE tryptic peptides were unlabelled: [35S]methionine-labelling was used for tryptic peptide mapping, but long stretches of the predicted amino acid sequence of gE lack methionine residues; any tryptic peptides contained within these stretches would not be seen on autoradiographs. Fourth, not all of gE is accessible to trypsin but only that region which contains 32K/34K/35K and 55K/57K. Fifth, the modification of gE yielding 32K/34K/35K and 55K/57K may not involve proteolytic cleavage.
The 32K/34K/35K and 55K/57K polypeptides are generated from gE-1 by a serum component or components. The fact that they were generated on BSA-anti-BSA columns and on fl-galactosidase-anti-fl-galactosidase columns initially suggested that immunoglobulin might be involved, although it is not known to have proteolytic activity. However subsequent experiments showed that purified immunoglobulin did not modify isolated gE-1 to yield 32K/34K/35K. Thus it appears that other bound serum components were responsible for the modification. Interestingly, the addition of human serum to the infected cell monolayers generated principally 55K/57K and much lower amounts of 32K/34K/35K than were found with rabbit or calf sera ( Fig. 8 and 9 ). If 55K/57K and 32K/34K/35K were generated by a single enzyme common to all three sera then the two groups of proteins would be expected to be generated in the same ratio by all sera. Since this was not the case other mechanisms must be postulated. It is possible that one enzyme is responsible for producing 55K/57K and a second enzyme is responsible for producing 32K/34K/35K and that human serum is relatively deficient in the second enzyme. A second possibility is that a single enzyme is responsible for generating both groups of polypeptides but that the enzymes of each of the three species have slightly different preferred modification sites.
The 32K/34K/35K polypeptides appear in the medium of infected cells in large amounts (Hope et al., 1982) and from early in the cycle of infection (unpublished observations). It seems likely that this process has a function, but what it is remains obscure especially as the physiological role of the herpesvirus-induced Fc-receptor has not been elucidated. Since the 32K/34K/35K polypeptides have no Fc-binding ability they can only bind antibody directed towards themselves and gE. They could only adsorb a small amount of the antibody generated by an HSV infection, and are unlikely to protect virus or virus-infected cells. Release of large amounts of the polypeptides from virus-infected cells in vivo might be expected to boost antibody levels. However in animal experiments injection of HSV-l-infected cells did not produce detectable amounts of antibody to the 32K/34K/35K polypeptides, nor is antibody to gE a major part of the immune response (unpublished observations). Further experiments are needed to elucidate the role of these polypeptides in HSV infections. Their role is unlikely to be understood from tissue culture experiments alone, since it has recently been demonstrated that gE is not essential for virus growth in tissue culture (Longnecker & Roizman, 1986) .
